- £37.78m
- £20.20m
- £1.04m
- 20
- 12
- 39
- 12
REG - Angle PLC - US and EU patents for innovative CellKeep™ slide
AnnouncementRCS - Angle PLC - Parsortix HER2 assay showcased at AACR 2024
AnnouncementRCS - Angle PLC - Parsortix at European breast cancer conference
AnnouncementRCS - Angle PLC - Potential utility in precision oncology
AnnouncementREG - Angle PLC - Standard form for notification of major holdings
AnnouncementREG - Angle PLC - Breakthrough clinical results
AnnouncementREG - Angle PLC - Contract announcement with Eisai Inc.
AnnouncementRCS - Angle PLC - Parsortix unlocks opportunities for drug discovery
AnnouncementREG - Angle PLC - Broker Announcement
AnnouncementRCS - Angle PLC - ANGLE launches Portrait+ CTC kit at SABCS
AnnouncementRCS - Angle PLC - Launch of PD-L1 test to support cancer studies
AnnouncementREG - Angle PLC - Trading and business update
AnnouncementRCS - Angle PLC - Supporting characterisation of CTCs in HNSCC
AnnouncementRCS - Angle PLC - Parsortix outperforms standard for DTC harvest
AnnouncementRCS - Angle PLC - Parsortix system showcased at ACTC conference
AnnouncementREG - Angle PLC - Interim Results for the period ended 30 June 2023
AnnouncementRCS - Angle PLC - ANGLE launch of Portrait Flex assay
AnnouncementREG - Angle PLC - ANGLE notice of interim results
AnnouncementREG - Angle PLC - Result of 2023 Annual General Meeting
Announcement